TELA Bio, Inc. (TELA) › Operating Cash FlowTELA Bio, Inc. (TELA) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2017: -$16.37M2018: -$19.92M2019: -$25.52M2020: -$24.46M2021: -$30.43M2022: -$40.75M2023: -$40.86M2024: -$41.59M2025: -$28.22M-$28.22M2017Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$28.22M+32.2%2024-$41.59M-1.8%2023-$40.86M-0.3%2022-$40.75M-33.9%2021-$30.43M-24.4%2020-$24.46M+4.2%2019-$25.52M-28.1%2018-$19.92M-21.7%2017-$16.37M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share